We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.00
Bid: 53.50
Ask: 56.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.607%)
Open: 55.00
High: 55.00
Low: 55.00
Prev. Close: 55.00
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change in management arrangements

8 Nov 2018 17:09

RNS Number : 8375G
Baronsmead Second Venture Trust PLC
08 November 2018
 

Baronsmead Second Venture Trust plc (the "Company")

 

Change in management arrangements

 

Livingbridge VC LLP ("Livingbridge") has today announced the sale of its fund and investment management business, including its Baronsmead VCT business, to a subsidiary of Gresham House plc ("Gresham House"), a specialist alternative asset manager listed on the London Stock Exchange. The core management, investment and operational teams involved with the Company will all be transferred to Gresham House in connection with this transaction.

 

A wide ranging and multi-year partnership agreement has been put in place between Livingbridge and Gresham House to enable a smooth transition of the management of the VCTs and also ongoing support between the parties to ensure minimal disruption for the Company and its Shareholders

 

The Company has consented to the novation of the existing investment management and co-investment agreements to Gresham House, which is expected to become effective around 30 November 2018. No changes are being made to the terms of the investment management and co-investment agreements.

 

The Board believes that this transaction is encouraging as it will provide additional resources for the team and enable them to focus on maintaining and developing the VCT business going forward. We understand that Gresham House intends to grow its non VCT private equity funds in the future and we see this as being complementary and supportive to the investment capability for the VCTs. The Board will continue to keep the performance of the management team under review and will update the shareholders on the new arrangements at the next Annual General Meeting.

 

Anthony Townsend, Chairman of the Company, is also Non-Executive Chairman of Gresham House. Accordingly, he will be stepping down as Chairman of the Company, but will remain as a non-executive director, following completion of the sale.

 

The Chairman of Baronsmead Venture Trust and the Senior Independent Director of Baronsmead Second Venture Trust said:

 

"The Baronsmead VCTs were some of the very first VCTs to be established and have built a strong reputation for quality and consistent performance. In Gresham House we have a manager that recognises the important heritage of the Baronsmead VCTs and that is committed to helping to deliver consistent performance over the long term for shareholders.

 

We are delighted that the existing team are all moving over to Gresham House and we believe through this transaction they will be able to focus their efforts on deploying capital and managing investments, benefit from additional investment in both team and resources, and continue to deliver returns to Shareholders."

 

Wol Kolade, Managing Partner at Livingbridge said:

"We are immensely proud of all that the Baronsmead team has achieved but as our core PE business is the central focus of our future growth plans, we have taken this decision because we know Gresham House will be an outstanding guardian of the Baronsmead VCTs and will invest in their growth for the benefit of shareholders for many years to come. 

"We would not be taking this step if we hadn't found Gresham House to be a high-quality and ambitious group, focused on performance and governance in the same way we are, and I look forward to working with Anthony Dalwood and his team to deliver a smooth transition and build a longer-term relationship."

 

For further information, please contact:

 

Baronsmead VCT Investor Relations

Telephone - 020 7506 5717

baronsmeadvcts@livingbridge.com

 

Douglas Armstrong

Dickson Minto W.S. (Adviser to the Boards)

Telephone - 020 7649 6823

 

Notes

 

Gresham House is a specialist alternative asset manager providing funds, direct investments and tailored investment solutions, including co-investment across a range of highly differentiated alternative investment strategies. The Group's expertise includes strategic public and private equity, timber, renewable energy, housing and infrastructure. 

 

Legal Entity Identifier: 213800VQ1PQHOJXDDQ88

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFSIFWAFASESF
Date   Source Headline
21st Jul 20219:30 amRNSNet Asset Value(s)
1st Jul 202110:29 amRNSTotal Voting Rights
9th Jun 20216:23 pmRNSTransaction in Own Shares
4th Jun 20216:00 pmRNSNet Asset Value(s)
27th May 20213:35 pmRNSHalf-year Report
7th May 20214:15 pmRNSNet Asset Value(s)
15th Apr 20215:00 pmRNSNet Asset Value(s)
1st Apr 202110:16 amRNSTotal Voting Rights
30th Mar 20216:01 pmRNSTransaction in Own Shares
18th Mar 20213:22 pmRNSIssue of New Shares
9th Mar 202112:03 pmRNSSale of shares from Treasury
3rd Mar 20215:15 pmRNSNet Asset Value(s)
2nd Mar 202112:41 pmRNSOffer for Subscription - Update
1st Mar 202112:43 pmRNSTotal Voting Rights
26th Feb 202111:26 amRNSIssue of New Shares
16th Feb 20215:14 pmRNSResult of AGM
15th Feb 20219:22 amRNSUpdate on Fundraising
5th Feb 202110:00 amRNSNet Asset Value(s)
1st Feb 202112:22 pmRNSTotal Voting Rights
29th Jan 20211:30 pmRNSIssue of New Shares
27th Jan 20215:30 pmRNSTransaction in Own Shares
27th Jan 202111:27 amRNSPublication of Supplementary Prospectus
21st Jan 20215:45 pmRNSNet Asset Value(s)
6th Jan 202110:37 amRNSUpdate on Fundraising
4th Jan 202112:05 pmRNSTotal Voting Rights
18th Dec 20207:00 amRNSIssue of Equity
17th Dec 20205:45 pmRNSTransaction in Own Shares
14th Dec 202012:27 pmRNSAppointment of Non-Executive Director
4th Dec 20204:15 pmRNSNet Asset Value(s)
3rd Dec 20206:00 pmRNSAnnual Financial Report For Y/E 30/09/20
1st Dec 202010:37 amRNSTotal Voting Rights
27th Nov 20201:05 pmRNSCorrection: Directorate Change
25th Nov 20203:51 pmRNSDirectorate Change
10th Nov 20203:08 pmRNSDirector/PDMR Shareholding
10th Nov 20202:58 pmRNSDirector/PDMR Shareholding
10th Nov 20202:44 pmRNSDirector/PDMR Shareholding
10th Nov 20202:41 pmRNSDirector/PDMR Shareholding
10th Nov 20201:44 pmRNSIssue of New Shares
5th Nov 20201:00 pmRNSNet Asset Value(s)
2nd Nov 202011:15 amRNSTotal Voting Rights
27th Oct 20203:51 pmRNSTransaction in Own Shares
20th Oct 20207:00 amRNSNet Asset Value(s)
14th Oct 202011:01 amRNSManagement Engagement & Remuneration Committee
7th Oct 20205:10 pmRNSOffer update – Extension of Earlybird Rebate
1st Oct 202011:00 amRNSTotal Voting Rights
29th Sep 202011:22 amRNSTransaction in Own Shares
17th Sep 20209:00 amRNSPublication of a Prospectus
11th Sep 20204:44 pmRNSTransaction in Own Shares
3rd Sep 20203:30 pmRNSNet Asset Value(s)
6th Aug 20202:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.